Liver Disease

• CLINICAL_TRIALS withdrawal · 2026-04-14
  Clinical Trial Update: Increlex Treatment of Children With Chronic Liver Disease and Short Stature [NA]

  A pediatric trial of Increlex (mecasermin) for growth failure associated with chronic liver disease has been withdrawn. The study was sponso…

• CLINICAL_TRIALS withdrawal · 2024-11-19
  Clinical Trial Update: Endoscopic Ultrasound Guided Liver Biopsy and Portal Pressure Registry

  A registry trial evaluating endoscopic ultrasound-guided liver biopsy and portal pressure measurements has been withdrawn from ClinicalTrial…

• CLINICAL_TRIALS withdrawal · 2018-06-18
  Clinical Trial Update: Minocycline Administration During Human Liver Transplantation [Phase 4]

  This Phase 4 trial evaluating minocycline administration during human liver transplantation has been withdrawn.

• CLINICAL_TRIALS withdrawal · 2018-04-19
  Clinical Trial Update: Inhibition of VAP-1 by Caffeine in Healthy Human Volunteers Study [Phase 1]

  Phase 1 trial evaluating caffeine as an inhibitor of VAP-1 in healthy volunteers was withdrawn; the study was associated with liver disease …

• CLINICAL_TRIALS withdrawal · 2017-12-08
  Clinical Trial Update: Compassionate Use of Omegaven IV Fat Emulsion

  Compassionate-use access to Omegaven IV fat emulsion for cholestasis and liver disease is no longer available.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS withdrawal · 2017-10-11
  Clinical Trial Update: A Study to Investigate the Pharmacokinetics, Safety, and Tolerability of Odalasvir and AL-335 Alone and in Combination With Simeprevir in Participants With Moderately Impaired Hepatic Function [Phase 1]

  A Phase 1 study evaluating Odalasvir and AL-335 alone and in combination with Simeprevir in participants with moderately impaired hepatic fu…

• CLINICAL_TRIALS withdrawal · 2016-06-21
  Clinical Trial Update: Enteral Fish Oil is Superior to Ursodeoxycholic Acid (UDCA) and Placebo for the Treatment of Cholestasis in Infants [Phase 2]

  The Phase 2 trial evaluating enteral fish oil for cholestasis in infants has been withdrawn.

• CLINICAL_TRIALS withdrawal · 2015-05-27
  Clinical Trial Update: Continuous Renal Replacement Therapy in the Setting of Orthotopic Liver Transplant [NA]

  The clinical trial NCT01619449 evaluating continuous renal replacement therapy in the setting of orthotopic liver transplantation has been w…

• CLINICAL_TRIALS withdrawal · 2015-03-18
  Clinical Trial Update: Clinical Study of Lyophilized Plasma in Patients With Liver Disease [Phase 2]

  A Phase 2 trial evaluating lyophilized plasma for liver disease was withdrawn.